Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%
- Check14 days agoChange DetectedThe webpage has undergone significant updates, including the addition of various facility names and locations across multiple countries, while also removing outdated location references and terms. Notably, the term 'IgA Nephropathy' has been replaced with 'IgA glomerulonephritis', indicating a shift in terminology.SummaryDifference10%
- Check21 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.2%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.2%
- Check45 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.